Literature DB >> 28235816

Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease.

Jennifer G Goldman1, Ian O Bledsoe2, Doug Merkitch2, Vy Dinh2, Bryan Bernard2, Glenn T Stebbins2.   

Abstract

OBJECTIVE: To investigate atrophy of the corpus callosum on MRI in Parkinson disease (PD) and its relationship to cognitive impairment.
METHODS: One hundred patients with PD and 24 healthy control participants underwent clinical and neuropsychological evaluations and structural MRI brain scans. Participants with PD were classified as cognitively normal (PD-NC; n = 28), having mild cognitive impairment (PD-MCI; n = 47), or having dementia (PDD; n = 25) by Movement Disorder Society criteria. Cognitive domain (attention/working memory, executive function, memory, language, visuospatial function) z scores were calculated. With the use of FreeSurfer image processing, volumes for total corpus callosum and its subsections (anterior, midanterior, central, midposterior, posterior) were computed and normalized by total intracranial volume. Callosal volumes were compared between participants with PD and controls and among PD cognitive groups, covarying for age, sex, and PD duration and with multiple comparison corrections. Regression analyses were performed to evaluate relationships between callosal volumes and performance in cognitive domains.
RESULTS: Participants with PD had reduced corpus callosum volumes in midanterior and central regions compared to healthy controls. Participants with PDD demonstrated decreased callosal volumes involving multiple subsections spanning anterior to posterior compared to participants with PD-MCI and PD-NC. Regional callosal atrophy predicted cognitive domain performance such that central volumes were associated with the attention/working memory domain; midposterior volumes with executive function, language, and memory domains; and posterior volumes with memory and visuospatial domains.
CONCLUSIONS: Notable volume loss occurs in the corpus callosum in PD, with specific neuroanatomic distributions in PDD and relationships of regional atrophy to different cognitive domains. Callosal volume loss may contribute to clinical manifestations of PD cognitive impairment.
© 2017 American Academy of Neurology.

Entities:  

Mesh:

Year:  2017        PMID: 28235816      PMCID: PMC5373777          DOI: 10.1212/WNL.0000000000003764

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  40 in total

1.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

Review 2.  Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative.

Authors:  Clifford R Jack; Matt A Bernstein; Bret J Borowski; Jeffrey L Gunter; Nick C Fox; Paul M Thompson; Norbert Schuff; Gunnar Krueger; Ronald J Killiany; Charles S Decarli; Anders M Dale; Owen W Carmichael; Duygu Tosun; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

3.  Topography of the human corpus callosum revisited--comprehensive fiber tractography using diffusion tensor magnetic resonance imaging.

Authors:  Sabine Hofer; Jens Frahm
Journal:  Neuroimage       Date:  2006-07-18       Impact factor: 6.556

4.  Cognitive status correlates with white matter alteration in Parkinson's disease.

Authors:  Takaaki Hattori; Satoshi Orimo; Shigeki Aoki; Kenji Ito; Osamu Abe; Atsushi Amano; Ryo Sato; Kasumi Sakai; Hidehiro Mizusawa
Journal:  Hum Brain Mapp       Date:  2011-04-14       Impact factor: 5.038

5.  Probabilistic topography of human corpus callosum using cytoarchitectural parcellation and high angular resolution diffusion imaging tractography.

Authors:  Yi-Ping Chao; Kuan-Hung Cho; Chun-Hung Yeh; Kun-Hsien Chou; Jyh-Horng Chen; Ching-Po Lin
Journal:  Hum Brain Mapp       Date:  2009-10       Impact factor: 5.038

6.  In vivo quantification of global connectivity in the human corpus callosum.

Authors:  Kevin Jarbo; Timothy Verstynen; Walter Schneider
Journal:  Neuroimage       Date:  2011-10-02       Impact factor: 6.556

7.  Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests?

Authors:  Jennifer G Goldman; Samantha Holden; Bichun Ouyang; Bryan Bernard; Christopher G Goetz; Glenn T Stebbins
Journal:  Mov Disord       Date:  2014-12-01       Impact factor: 10.338

8.  What contributes to quality of life in patients with Parkinson's disease?

Authors:  A Schrag; M Jahanshahi; N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

Review 9.  Corpus callosum in aging and dementia.

Authors:  Kristian Steen Frederiksen
Journal:  Dan Med J       Date:  2013-10       Impact factor: 1.240

10.  The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.

Authors:  Caroline H Williams-Gray; Sarah L Mason; Jonathan R Evans; Thomas Foltynie; Carol Brayne; Trevor W Robbins; Roger A Barker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-06-18       Impact factor: 10.154

View more
  23 in total

Review 1.  Cognitive and behavioral disorders in Parkinson's disease: an update. I: cognitive impairments.

Authors:  Costanza Papagno; Luigi Trojano
Journal:  Neurol Sci       Date:  2017-10-17       Impact factor: 3.307

Review 2.  The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

Authors:  Daniel Weintraub; Eugenia Mamikonyan
Journal:  Am J Geriatr Psychiatry       Date:  2019-03-09       Impact factor: 4.105

3.  Deep learning to differentiate parkinsonian disorders separately using single midsagittal MR imaging: a proof of concept study.

Authors:  Shigeru Kiryu; Koichiro Yasaka; Hiroyuki Akai; Yasuhiro Nakata; Yusuke Sugomori; Seigo Hara; Maria Seo; Osamu Abe; Kuni Ohtomo
Journal:  Eur Radiol       Date:  2019-07-01       Impact factor: 5.315

4.  Primary CNS lymphoma of the corpus callosum: presentation and neurocognitive outcomes.

Authors:  Christelle Nilles; Daniel Delgadillo; Marie Sarazin; Lucia Nichelli; Karima Mokhtari; Bertrand Mathon; Sylvain Choquet; Loïc Feuvret; Agusti Alentorn; Monica Ribeiro; Khê Hoang-Xuan; Caroline Houillier
Journal:  J Neurooncol       Date:  2022-04-21       Impact factor: 4.130

5.  Dysregulation of mitochondrial and proteolysosomal genes in Parkinson's disease myeloid cells.

Authors:  Elisa Navarro; Evan Udine; Katia de Paiva Lopes; Madison Parks; Giulietta Riboldi; Brian M Schilder; Jack Humphrey; Gijsje J L Snijders; Ricardo A Vialle; Maojuan Zhuang; Tamjeed Sikder; Charalambos Argyrou; Amanda Allan; Michael J Chao; Kurt Farrell; Brooklyn Henderson; Sarah Simon; Deborah Raymond; Sonya Elango; Roberto A Ortega; Vicki Shanker; Matthew Swan; Carolyn W Zhu; Ritesh Ramdhani; Ruth H Walker; Winona Tse; Mary Sano; Ana C Pereira; Tim Ahfeldt; Alison M Goate; Susan Bressman; John F Crary; Lotje de Witte; Steven Frucht; Rachel Saunders-Pullman; Towfique Raj
Journal:  Nat Aging       Date:  2021-09-14

6.  An antioxidant and anti-ER stress combo therapy decreases inflammation, secondary brain damage and promotes neurological recovery following traumatic brain injury in mice.

Authors:  Charles K Davis; Saivenkateshkomal Bathula; Martin Hsu; Kahlilia C Morris-Blanco; Anil K Chokkalla; Soomin Jeong; Jeongwoo Choi; Shruti Subramanian; Jin Soo Park; Zsuzsanna Fabry; Raghu Vemuganti
Journal:  J Neurosci       Date:  2022-07-25       Impact factor: 6.709

7.  Alterations of regional homogeneity in Parkinson's disease with mild cognitive impairment: a preliminary resting-state fMRI study.

Authors:  Ming-Ge Li; Tie-Fang Liu; Tian-Hao Zhang; Zhi-Ye Chen; Bin-Bin Nie; Xin Lou; Zhen-Fu Wang; Lin Ma
Journal:  Neuroradiology       Date:  2019-12-10       Impact factor: 2.804

8.  White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease.

Authors:  Ian O Bledsoe; Glenn T Stebbins; Doug Merkitch; Jennifer G Goldman
Journal:  Neurology       Date:  2018-11-14       Impact factor: 9.910

Review 9.  Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression.

Authors:  Elizabeth R Wallace; Suzanne C Segerstrom; Craig G van Horne; Frederick A Schmitt; Lisa M Koehl
Journal:  Neuropsychol Rev       Date:  2021-04-16       Impact factor: 7.444

10.  Abnormalities in the white matter tracts in patients with Parkinson disease and psychosis.

Authors:  Abhishek Lenka; Madhura Ingalhalikar; Apurva Shah; Jitender Saini; Shyam Sundar Arumugham; Shantala Hegde; Lija George; Ravi Yadav; Pramod Kumar Pal
Journal:  Neurology       Date:  2020-04-21       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.